Our 4-amino-5-methyl-2-hydroxypyridine is a key intermediate in the synthesis of Finerenone, a new non-steroidal selective mineralocorticoid receptor antagonist with potential in the treatment of cardiovascular and renal diseases. Potential applications. This compound is a key component in the production of Finerenone, making it an important ingredient for pharmaceutical companies and research institutions. The purity and quality of our 4-amino-5-methyl-2-hydroxypyridine is unparalleled, ensuring its suitability for all stages of drug development and manufacturing. With a focus on excellence and innovation, we have optimized our synthesis and purification processes to provide products that meet the rigorous standards of the pharmaceutical industry. Our commitment to quality extends to every aspect of our operations, from raw material sourcing to manufacturing and distribution. We adhere to the highest safety and compliance standards to ensure our customers receive products that meet the strictest regulatory requirements.JDK owns the first-class production facilities and Quality management equipments, which assures the stable supply of API intermediates. Professional team assure R&D of the product. Against both, we are searching for CMO & CDMO in domestic and international market.